Ukr.Biochem.J. 2023; Volume 95, Issue 5, Sep-Oct, pp. 22-30

doi: https://doi.org/10.15407/ubj95.05.022

Assessing the relationship between organ function test results and COVID-19 severity

02.11.2023   Uncategorized   No comments

A. K. Yadav1, M. K. Mishra2*, S. Prasad3, S. Singh4

1Department of Biochemistry, Heritage Institute of Medical Science, Varanasi, U.P., India;
2Department of Biochemistry, GMERS Medical College & Hospital, Vadnagar, Gujarat, India;
3Department of Biochemistry, K. J. Somaiya Medical College & Research Centre, Mumbai, India;
4Department of Microbiology, Integral Institute of Medical Science and Research, Lucknow, U.P., India;
*e-mail: mritunjaymishra007@gmail.com

Received: 25 July 2023; Revised: 12 October 2023;
Accepted: 27 October 2023; Available on-line: 06 November 2023

A number of recent reports have indicated the association of COVID-19 with multiple organ failure and the need to clarify the relationship between organ testing parameters and disease progression. Therefore, this study aimed to determine the degree of abnormal organ function test parameters and its correlation with COVID-19 severity. A cross-sectional study was conducted among COVID-19 patients admitted at Sanaka hospital, India, from August to September 2020. A total of 100 qRT-PCR-confirmed COVID-19 patients divided into groups with mild or severe cases were enrolled. The data from venous blood samples for liver, renal, cardiac and inflammatory test parameters were included from the Sanaka hospital laboratory database. Biochemical prognostic tests were carried out using a clinical automated ERBA analyzer, cardiac markers were estimated with Enzyme Linked Fluorescent Assay. The Pearson correlation analysis was used to analyze the data. Aspartate/Alanine aminotransferases and alkaline phosphatase activity, creatinine, urea and troponin levels were higher in the confirmed positive cases of COVID-19. Significantly higher levels of troponin, D-dimer and C reactive protein (CRP) were found in patients with severe COVID form compared to a mild one. A strong positive correlation between elevated D-dimer and Ferritin with CRP level was revealed in this group of patients. It was concluded that the positive relationship between serum D-dimer, ferritin levels and CRP level in patients can be considered a stable indicator of disease severity.

Keywords: , , , , ,

References:

  1. Dong Y, Liang X, Yu X. Prognostic value of the dynamic changes in extra vascular lung water index and angiopoietin-2 in severe multiple trauma patients with acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(5):571-576. PubMed, CrossRef
  2. Tezcan ME, Gökçe GD, Ozer RS. Laboratory abnormalities related to prolonged hospitalization in COVID-19. Infect Dis (Lond). 2020;52(9):666-668. PubMed, CrossRef
  3. World Health Organization. Who coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/info, no.8, 2020.
  4. Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):640. PubMed, PubMedCentral, CrossRef
  5. Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302-310. PubMed, PubMedCentral, CrossRef
  6. Castro VM, McCoy TH, Perlis RH. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts. JAMA Netw Open. 2020;3(10):e2023934. PubMed, PubMedCentral, CrossRef
  7. Piñeiro GJ, Molina-Andújar A, Hermida E, Blasco M, Quintana LF, Rojas GM, Mercadal J, Castro P, Sandoval E, Andrea R, Fernández J, Badia JR, Soriano A, Poch E. Severe acute kidney injury in critically ill COVID-19 patients. J Nephrol. 2021;34(2):285-293. PubMed, PubMedCentral, CrossRef
  8. Qu J, Zhu HH, Huang XJ, He GF, Liu JY, Huang JJ, Chen Y, Qu Q, Wu YL, Chen XY, Lu Q. Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist. 2021;14:3029-3040. PubMed, PubMedCentral, CrossRef
  9. Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18(7):1747-1751. PubMed, PubMedCentral, CrossRef
  10. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Regime of access: https://www.who.int/publications/i/item/10665-332299.
  11. Pan Y, Ye G, Zeng X, Liu G, Zeng X, Jiang X, Zhao J, Chen L, Guo S, Deng Q, Hong X, Yang Y, Li Y, Wang X. Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Clin Transl Med. 2020;10(1):161-168. PubMed, PubMedCentral, CrossRef
  12. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40(9):2095-2103. PubMed, CrossRef
  13. 13. Chen Z, Zhang F, Hu W, Chen Q, Li C, Wu L, Zhang Z, Li B, Ye Q, Mei J, Yue J. Laboratory markers associated with COVID-19 progression in patients with or without comorbidity: A retrospective study. J Clin Lab Anal. 2021;35(1):e23644. PubMed, PubMedCentral, CrossRef
  14. Assandri R, Buscarini E, Canetta C, Scartabellati A, Viganò G, Montanelli A. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room. Arch Med Res. 2020;51(6):598-599. PubMed, PubMedCentral, CrossRef
  15. Chen X, Yan L, Fei Y, Zhang C. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19. J Clin Lab Anal. 2020;34(10):e23467. PubMed, PubMedCentral, CrossRef
  16. Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg. 2020;103(5):1783-1796. PubMed, PubMedCentral, CrossRef
  17. Piano S, Dalbeni A, Vettore E, Benfaremo D, Mattioli M, Gambino CG, Framba V, Cerruti L, Mantovani A, Martini A, Luchetti MM, Serra R, Cattelan A, Vettor R, Angeli P. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19. Liver Int. 2020;40(10):2394-2406. PubMed, PubMedCentral, CrossRef
  18. Gupta N, Ish P, Kumar R, Dev N, Yadav SR, Malhotra N, Agrawal S, Gaind R, Sachdevav H. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India. Monaldi Arch Chest Dis. 2020;90(4):1507. PubMed, PubMedCentral, CrossRef
  19. Cappell MS. Moderately Severe Diarrhea and Impaired Renal Function With COVID-19 Infection. Am J Gastroenterol. 2020;115(6):947-948. PubMed, PubMedCentral, CrossRef
  20. Atallah B, Mallah SI, AbdelWareth L, AlMahmeed W, Fonarow GC. A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients? Eur Heart J Qual Care Clin Outcomes. 2020;6(3):204-207. PubMed, PubMedCentral, CrossRef
  21. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X , Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. PubMed, PubMedCentral, CrossRef
  22. Berger JS, Kunichoff D, Adhikari S, Ahuja T, Amoroso N, Aphinyanaphongs Y, Cao M, Goldenberg R, Hindenburg A, Horowitz J, Parnia S, Petrilli C, Reynolds H, Simon E, Slater J, Yaghi S, Yuriditsky E, Hochman J, Horwitz LI. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19. Arterioscler Thromb Vasc Biol. 2020;40(10):2539-2547. PubMed, PubMedCentral, CrossRef
  23. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324-1329. PubMed, PubMedCentral, CrossRef
  24. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. PubMed, PubMedCentral, CrossRef
  25. Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study. Liver Int. 2020;40(6):1321-1326. PubMed, PubMedCentral, CrossRef
  26. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812. PubMed, PubMedCentral, CrossRef
  27. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791-796. PubMed, PubMedCentral, CrossRef
  28. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang Y. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2021;73(11):e4208-e4213. PubMed, PubMedCentral, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.